Direct Antiviral Combination Treatment According to Presence of Baseline Ravs in NS3, NS5A and NS5B Leads to High SVR Rates in Non-Cirrhotic and Cirrhotic Genotype 1 Infected Patients

Direct Antiviral Combination Treatment According to Presence of Baseline Ravs in NS3, NS5A and NS5B Leads to High SVR Rates in Non-Cirrhotic and Cirrhotic Genotype 1 Infected Patients

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 64; no. 2; p. S404
Main Authors: Peiffer, K.-H, Susser, S, Dietz, J, Berkowski, C, Perner, D, Passmann, S, Raeder, M, Vermehren, J, Lange, C, Klein, S, Weiler, N, Zeuzem, S, Sarrazin, C
Format: Journal Article
Language:English
Published: 2016
Subjects:
Gastroenterology and Hepatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0168-8278
DOI:10.1016/S0168-8278(16)00640-1